Harpoon Therapeutics (HARP) Financials

$23.01

$0.00 (0.00%)

As on 11-Mar-2024 16:00EDT

Market cap

$492 Mln

Revenue (TTM)

$37 Mln

P/E Ratio

--

P/B Ratio

108.4

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Operating Revenue	37.34	31.92	23.65	17.44	5.78	4.75
Cost of Revenue	2.82	3.10	2.65	--	41.59	26.37
Gross Profit	34.52	31.92	21.01	17.44	5.78	4.75
Operating Expenses	74.74	100.24	90.45	68.78	63.98	32.47
Operating Profit (EBIT)	-39.12	-68.33	-116.75	-51.33	-58.21	-27.72
Other Income	--	--	-0.02	1.39	2.68	0.36
Profit before Tax	-30.50	-67.73	-116.72	-49.91	-55.57	-27.37
Provision for Tax	1.20	-0.59	49.71	-3.53	-3.58	0.36
Profit after Tax (Net Income)	-30.87	-67.14	-166.44	-46.38	-52.00	-27.37
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-16.30	-67.73	-116.72	-49.91	-55.57	-27.37

Liabilities ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Shareholder's Funds	4.54	5.40	58.07	53.84	94.22	-53.48
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	24.93	15.90	38.24	69.84	59.87	144.11
Current Liabilities	18.11	52.43	59.14	47.92	22.51	11.95
Total Liabilities	65.68	73.73	155.45	171.59	176.60	102.58

Assets ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Non-Current Assets	13.28	19.00	17.76	41.84	25.99	12.36
Current Assets	34.30	54.73	137.70	129.75	150.62	90.22
Total Assets	65.68	73.73	155.45	171.59	176.60	102.58
Total Debt*	14.50	16.01	12.19	13.52	14.94	--
Net Current Assets	16.19	2.29	78.56	81.84	128.10	78.28

Cashflow ($ Mln)	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Cash From Operating Activities	--	-89.18	-122.15	-8.62	-2.89	-27.13
Cash Flow from Investing Activities	--	89.74	34.35	-63.63	-69.32	-0.66
Cash from Financing Activities	--	6.37	111.52	4.68	71.45	88.33
Net Cash Inflow / Outflow	--	--	23.72	-67.57	-0.76	60.54

Financials Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Adjusted EPS ($)	-8.80	-19.93	-50.89	-18.37	-21.13	-11.45
Cash EPS ($)	--	-19.23	-50.22	-17.54	-20.76	-11.18
Adjusted Book Value ($)	--	1.60	17.76	21.32	38.29	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-26.48	-37.35	-3.41	-1.17	-11.35
Free Cash Flow per Share ($)	--	-26.58	-37.38	-3.68	-2.60	-11.62

Profitability Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
ROCE (%)	--	-146.49	-241.89	-52.55	-186.75	68.06
ROE (%)	-1,174.47	-211.56	-297.45	-62.65	-255.25	68.06
ROA (%)	-30.37	-58.59	-101.78	-26.64	-37.25	-40.71
EBIT Margin (%)	-102.25	-214.08	-493.58	-294.26	-1,007.55	-589.68
Net Margin (%)	-82.66	-210.36	-704.22	-246.31	-615.19	-535.75
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Revenue Growth (%)	16.14	0.35	0.36	2.02	0.22	5.71
EBIT Growth (%)	46.34	41.48	-127.45	11.81	-107.80	-69.30
Net Profit Growth (%)	56.26	59.66	-258.87	10.81	-90.00	-62.60
EPS Growth (%)	58.97	0.61	-1.77	0.13	-0.85	0.36
Book Value Growth (%)	-77.51	--	--	--	--	--

Valuation Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Price / Earnings	--	-0.04	-0.15	-0.90	-0.70	--
Price / Book Value	108.42	0.45	0.43	0.78	0.39	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-18.71	0.53	6.70	1.43	2.85	--
Close Price ($)	4.03	7.26	75.50	166.10	147.90	--
High Price ($)	33.55	82.00	252.35	250.20	214.70	--
Low Price ($)	3.86	5.86	55.30	102.70	90.65	--
Market Cap ($ Cr)	492.35	--	--	--	--	--

Solvency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debt to Equity	--	2.96	0.21	0.25	0.16	--
Short term debt to equity ratio	0.65	0.45	0.03	0.02	0.01	--
Current Ratio	1.89	1.04	2.33	2.71	6.69	7.55
Quick Ratio	1.89	--	--	--	--	--
Interest Coverage	-6.46	-115.03	-3,891.70	--	--	--

Operating Efficiency Ratios	TTM	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13
Debtors to sales (%)	--	--	3.64	--	--	--
Asset Turnover	0.37	0.28	0.14	0.10	0.04	0.07
Receivable days	--	9.84	13.28	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	435.07	292.50	--	30.52	38.31
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.